Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas. (Q39652963)

From Wikidata

Jump to navigation Jump to search

scientific article published on October 2011

Language	Label	Description	Also known as
English	Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas.	scientific article published on October 2011

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Radiosynthesis and initial in vitro evaluation of [18F]F-PEG6-IPQA--a novel PET radiotracer for imaging EGFR expression-activity in lung carcinomas (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1

object named as

Ashutosh Pal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Julius A Balatoni

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Uday Mukhopadhyay

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Carlos Gonzalez-Lepera

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Aleksandr Shavrin

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Andrei Volgin

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

William Tong

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mian M Alauddin

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Juri G Gelovani

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 October 2011

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Molecular Imaging and Biology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

853-861

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1007/s11307-010-0408-8

0 references

Cancer molecular imaging: radionuclide-based biomarkers of the epidermal growth factor receptor (EGFR).

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Strategies for molecular imaging of epidermal growth factor receptor tyrosine kinase in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Molecular imaging of epidermal growth factor receptor expression-activity at the kinase level in tumors with positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Gefitinib induces apoptosis in the EGFRL858R non-small-cell lung cancer cell line H3255.

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Synthetic approaches to a variety of covalently linked porphyrin--fullerene hybrids

1 reference

https://api.crossref.org/works/10.1007%2FS11307-010-0408-8

21 January 2018

Evaluation of modified PEG-anilinoquinazoline derivatives as potential agents for EGFR imaging in cancer by small animal PET.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130206

1 October 2018

Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130206

1 October 2018

Further characterization of the epidermal growth factor receptor ligand 11C-PD153035.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6130206

1 October 2018

The effect of the [18F]-PEG group on tracer qualification of [4-(phenylamino)-quinazoline-6-YL]-amide moiety--an EGFR putative irreversible inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/20859697

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual irreversible kinase inhibitors: quinazoline-based inhibitors incorporating two independent reactive centers with each targeting different cysteine residues in the kinase domains of EGFR and VEGFR-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20859697

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11307-010-0408-8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20859697%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39652963&oldid=1787844241"